Preliminary drug trial results give hope to those with a common form of muscular dystrophy
Kansas City, Kansas and Paris, France. What do they have in common?
Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use